Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Smith JW 2nd"'
Autor:
Janik JE, Miller LL, Longo DL, Powers GC, Urba WJ, Kopp WC, Gause BL, Curti BD, Fenton RG, Oppenheim JJ, Conlon KC, Holmlund JT, Sznol M, Sharfman WH, Steis RG, Creekmore SP, Alvord WG, Beauchamp AE, Smith JW 2nd, Janik, J E
Publikováno v:
JNCI: Journal of the National Cancer Institute; 1/3/96, Vol. 88 Issue 1, p44-49, 6p
Autor:
Tepler, I, Elias, L, Smith, JW 2nd, Hussein, M, Rosen, G, Chang, AY, Moore, JO, Gordon, MS, Kuca, B, Beach, KJ, Loewy, JW, Garnick, MB, Kaye, JA
Publikováno v:
Blood; May 1996, Vol. 87 Issue: 9 p3607-3614, 8p
Autor:
Steven M. Larson, Michael A. Bookman, Richard P. McCabe, John W. Smith, Jeffrey W. Clark, Ronald G. Steis, James C. Reynolds, V Dailey, Jorge A. Carrasquillo, S. Del Vecchio
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 8(3)
Two human immunoglobulin M (IgM) monoclonal antibodies (MoAbs), 16.88 and 28A32, which react with cytoplasmic (28A32 and 16.88) or cell surface (28A32) determinants on human colon carcinoma cells, were administered intravenously to 26 patients with m
Autor:
Holmes FA; Texas Oncology, P.A., US Oncology Research, Houston, TX, USA. Electronic address: faholmesmd@icloud.com., Moy B; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Delaloge S; Institut Gustave Roussy, Villejuif, France., Chia SKL; BC Cancer Agency, Vancouver, BC, Canada., Ejlertsen B; Rigshospitalet, Copenhagen, Denmark., Mansi J; Guy's and St Thomas Hospital NHS Foundation Trust and Biomedical Research Centre, King's College, London, United Kingdom., Iwata H; Aichi Cancer Center, Chikusa-ku, Nagoya, Japan., Gnant M; Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria., Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Barrios CH; Hospital São Lucas, PUCRS, Porto Alegre, Brazil., Silovski T; Department of Oncology, UHC Zagreb, Zagreb, Croatia., Šeparović R; University Hospital for Tumors, University Hospital Center 'Sestre Milosrdnice', Zagreb, Croatia., Bashford A; Auckland Hospital, Auckland, New Zealand., Zotano AG; Instituto Valenciano de Oncologia, València, Spain., Denduluri N; Virginia Cancer Specialists, US Oncology Research, Arlington, VA, USA., Patt D; Texas Oncology - Round Rock, US Oncology Research, Austin, TX, USA., Gokmen E; Ege University Faculty of Medicine, Izmir, Turkey., Gore I; Alabama Oncology, Birmingham, AL, USA., Smith JW 2nd; Northwest Cancer Specialists, P.C., US Oncology Research, Vancouver, VA, USA., Loibl S; Center for Hematology and Oncology Bethanien, Frankfurt, Germany and German Breast Group, Neu-Isenburg, Germany., Masuda N; Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan., Tomašević Z; Daily Chemotherapy Hospital, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Petráková K; Masaryk Memorial Cancer Institute, Brno, Czech Republic., DiPrimeo D; Puma Biotechnology Inc., Los Angeles, CA, USA., Wong A; Puma Biotechnology Inc., Los Angeles, CA, USA., Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain., Chan A; Breast Cancer Research Centre-WA & Curtin University, Perth, Australia.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 May; Vol. 184, pp. 48-59. Date of Electronic Publication: 2023 Feb 10.
Autor:
Paoletti C; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; Currently at EISAI, Inc., Woodcliff Lake, NJ, USA., Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA., Niman SM; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA., Dolce EM; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Darga EP; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Liu MC; Department of Oncology, Division of Medical Oncology, and Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA., Marcom PK; Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham, NC, USA., Hart LL; Florida Cancer Specialists/Wake Forest School of Medicine, Fort Myers, FL, USA., Smith JW 2nd; US Oncology Research, Compass Oncology, Portland, OR, USA., Tedesco KL; New York Oncology Hematology, US Oncology Network, Albany, NY, USA., Amir E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Krop IE; Department of Medical Oncology, Division of Breast Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., DeMichele AM; Department of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA., Goodwin PJ; Department of Medicine, Sinai Health System, University of Toronto, Toronto, ON, Canada., Block M; Nebraska Cancer Specialists, Omaha, NE, USA., Aung K; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Brown ME; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., McCormack RT; Janssen Pharmaceuticals, Inc., Raritan, NJ, USA., Hayes DF; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA. hayesdf@umich.edu.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2021 Jun 11; Vol. 7 (1), pp. 77. Date of Electronic Publication: 2021 Jun 11.
Autor:
Smith JW 2nd; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Columbia River Oncology Program, Portland, OR., Buyse ME; International Drug Development Institute, Louvain-la-Neuve, Belgium., Rastogi P; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Medicine, Oncology, University of Pittsburgh Cancer Institute, and Magee-Womens Hospital Womens Cancer Clinic, Pittsburgh, PA. Electronic address: rastogip@upmc.edu., Geyer CE Jr; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA., Jacobs SA; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Medicine, Oncology, University of Pittsburgh Cancer Institute, and Magee-Womens Hospital Womens Cancer Clinic, Pittsburgh, PA., Patocskai EJ; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Centre hospitalier de l'Université de Montreal (CHUM), Montréal, Québec, Canada., Robidoux A; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Centre hospitalier de l'Université de Montreal (CHUM), Montréal, Québec, Canada., Conlin AK; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Western Oncology Research Consortium, Portland, OR., Ansari B; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Northern Indiana Cancer Research Consortium, Mishawaka, IN., Keogh GP; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Southeast Clinical Oncology Research Consortium, Roper St Francis Cancer Care, Charleston, SC., Stella PJ; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Michigan Cancer Research Consortium Community, Ann Arbor, MI., Gross HM; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Dayton, Dayton, OH., Lord RS; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Kalamazoo, and the West Michigan Cancer Center, Kalamazoo, MI., Polikoff JA; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Kaiser Permanente, San Diego, CA., Mauquoi C; International Drug Development Institute, Louvain-la-Neuve, Belgium., Mamounas EP; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Oncology, UF Cancer Center at Orlando Health, Orlando, FL., Swain SM; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC; Georgetown University Medical Center, Washington, DC., Wolmark N; National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2017 Feb; Vol. 17 (1), pp. 48-54.e3. Date of Electronic Publication: 2016 Jul 28.
Autor:
Smith JW 2nd; Compass Oncology, The US Oncology Network, Portland, OR. Electronic address: john.smith@usoncology.com., Vukelja S; Texas Oncology-Tyler, The US Oncology Network, Tyler, TX., Hoffman AD; Eastchester Center for Cancer Care, Bronx, NY., Jones VE; Yakima Valley Memorial Hospital-North Star Lodge Cancer Center, Yakima, WA., McIntyre K; Texas Oncology-Dallas Presbyterian Hospital, The US Oncology Network, Dallas, TX., Berrak E; Eisai Inc., Woodcliff Lake, NJ., Song JX; Eisai Inc., Woodcliff Lake, NJ., O'Shaughnessy J; Texas Oncology-Baylor Charles A. Sammons Cancer Center, The US Oncology Network, Dallas, TX.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2016 Feb; Vol. 16 (1), pp. 31-7. Date of Electronic Publication: 2015 Aug 06.
Autor:
Payne R; Providence Cancer Center, Providence Portland Medical Center, Earle A. Chiles Research Institute, 4805 NE Glisan Street, Portland, OR 97213, USA., Glenn L; Providence Cancer Center, Providence Portland Medical Center, Earle A. Chiles Research Institute, 4805 NE Glisan Street, Portland, OR 97213, USA., Hoen H; Providence Cancer Center, Providence Portland Medical Center, Earle A. Chiles Research Institute, 4805 NE Glisan Street, Portland, OR 97213, USA., Richards B; Providence Cancer Center, Providence Portland Medical Center, Earle A. Chiles Research Institute, 4805 NE Glisan Street, Portland, OR 97213, USA., Smith JW 2nd; Compass Oncology, 265 N Broadway, Portland, OR 97725, USA., Lufkin R; Compass Oncology, 265 N Broadway, Portland, OR 97725, USA., Crocenzi TS; Providence Cancer Center, Providence Portland Medical Center, Earle A. Chiles Research Institute, 4805 NE Glisan Street, Portland, OR 97213, USA., Urba WJ; Providence Cancer Center, Providence Portland Medical Center, Earle A. Chiles Research Institute, 4805 NE Glisan Street, Portland, OR 97213, USA., Curti BD; Providence Cancer Center, Providence Portland Medical Center, Earle A. Chiles Research Institute, 4805 NE Glisan Street, Portland, OR 97213, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2014 May 14; Vol. 2, pp. 13. Date of Electronic Publication: 2014 May 14 (Print Publication: 2014).
Autor:
Smith JW 2nd; Compass Oncology, 5050 NE Hoyt Street, Suite 256, Portland, OR, 97213, USA, john.smith@usoncology.com., Vukelja S, Rabe A, Wentworth-Hartung N, Koutrelakos N, Shao SH, Whittaker T, Wang Y, Asmar L, McDowell DO, Mukhopadhyay P, O'Shaughnessy J
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2013 Nov; Vol. 142 (2), pp. 381-8. Date of Electronic Publication: 2013 Oct 29.
Autor:
Robert NJ; Virginia Cancer Specialists, US Oncology, Fairfax, VA, USA. Nicholas.Robert@USONCOLOGY.COM, Saleh MN, Paul D, Generali D, Gressot L, Copur MS, Brufsky AM, Minton SE, Giguere JK, Smith JW 2nd, Richards PD, Gernhardt D, Huang X, Liau KF, Kern KA, Davis J
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2011 Apr; Vol. 11 (2), pp. 82-92. Date of Electronic Publication: 2011 Apr 11.